Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP818023.RAAA6PUm123a53C5lJhzQPT4VuKTnfldS4qBw8LhmKHz0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP818023.RAAA6PUm123a53C5lJhzQPT4VuKTnfldS4qBw8LhmKHz0130_assertion type Assertion NP818023.RAAA6PUm123a53C5lJhzQPT4VuKTnfldS4qBw8LhmKHz0130_head.
- NP818023.RAAA6PUm123a53C5lJhzQPT4VuKTnfldS4qBw8LhmKHz0130_assertion description "[LOH of both TP53 and RB1 were frequently found in IDC-P (52%), followed by extracapsular tumor tissue (44%), invasive cancer (24%), PIN (19%), and benign prostatic tissue (17%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP818023.RAAA6PUm123a53C5lJhzQPT4VuKTnfldS4qBw8LhmKHz0130_provenance.
- NP818023.RAAA6PUm123a53C5lJhzQPT4VuKTnfldS4qBw8LhmKHz0130_assertion evidence source_evidence_literature NP818023.RAAA6PUm123a53C5lJhzQPT4VuKTnfldS4qBw8LhmKHz0130_provenance.
- NP818023.RAAA6PUm123a53C5lJhzQPT4VuKTnfldS4qBw8LhmKHz0130_assertion SIO_000772 18383208 NP818023.RAAA6PUm123a53C5lJhzQPT4VuKTnfldS4qBw8LhmKHz0130_provenance.
- NP818023.RAAA6PUm123a53C5lJhzQPT4VuKTnfldS4qBw8LhmKHz0130_assertion wasDerivedFrom befree-20140225 NP818023.RAAA6PUm123a53C5lJhzQPT4VuKTnfldS4qBw8LhmKHz0130_provenance.
- NP818023.RAAA6PUm123a53C5lJhzQPT4VuKTnfldS4qBw8LhmKHz0130_assertion wasGeneratedBy ECO_0000203 NP818023.RAAA6PUm123a53C5lJhzQPT4VuKTnfldS4qBw8LhmKHz0130_provenance.